ProQR Therapeutics N.V. Miscellaneous Other Operating Income
ProQR Therapeutics N.V. (PRQR) reported Miscellaneous Other Operating Income of EUR 5.00 thousand for the 12-month period ending 2023-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Income Statement › Other Income
ifrs-full:MiscellaneousOtherOperatingIncome · last filed 2026-03-12
- ProQR Therapeutics N.V. miscellaneous other operating income for the quarter ending 2023-12-31 was 1.00K EUR, a 98.31% decline year-over-year.
- ProQR Therapeutics N.V. miscellaneous other operating income for the quarter ending 2023-09-30 was 0.00 EUR.
- ProQR Therapeutics N.V. miscellaneous other operating income for the quarter ending 2023-06-30 was 0.00 EUR, a 100.00% decline year-over-year.
- ProQR Therapeutics N.V. miscellaneous other operating income for the quarter ending 2023-03-31 was 4.00K EUR, a 20.00% decline year-over-year.
| Period end | Miscellaneous Other Operating Income 3 month | Miscellaneous Other Operating Income 6 month | Miscellaneous Other Operating Income 9 month | Miscellaneous Other Operating Income 12 month |
|---|---|---|---|---|
| 2023-12-31 | 1.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-03-12 | 1.00K EUR derived: sum of 2 quarters · filed 2026-03-12 | 1.00K EUR derived: sum of 3 quarters · filed 2026-03-12 | 5.00K EUR 20-F · filed 2026-03-12 |
| 2023-09-30 | 0.00 EUR derived: 6-K 9 month − 6-K 6 month · filed 2024-11-07 | 0.00 EUR derived: sum of 2 quarters · filed 2024-11-07 | 4.00K EUR 6-K · filed 2024-11-07 | 63.00K EUR derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-06-30 | 0.00 EUR derived: 6-K 6 month − 6-K 3 month · filed 2024-08-08 | 4.00K EUR 6-K · filed 2024-08-08 | 63.00K EUR derived: sum of 3 quarters · filed 2025-03-13 | 63.00K EUR derived: sum of 4 quarters · filed 2025-03-13 |
| 2023-03-31 | 4.00K EUR 6-K · filed 2024-05-09 | 63.00K EUR derived: sum of 2 quarters · filed 2025-03-13 | 63.00K EUR derived: sum of 3 quarters · filed 2025-03-13 | 65.00K EUR derived: sum of 4 quarters · filed 2025-03-13 |
| 2022-12-31 | 59.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-03-13 | 59.00K EUR derived: sum of 2 quarters · filed 2025-03-13 | 61.00K EUR derived: sum of 3 quarters · filed 2025-03-13 | 66.00K EUR 20-F · filed 2025-03-13 |
| 2022-09-30 | 0.00 EUR derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | 2.00K EUR derived: sum of 2 quarters · filed 2023-11-07 | 7.00K EUR 6-K · filed 2023-11-07 | 8.00K EUR derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-06-30 | 2.00K EUR derived: 6-K 6 month − 6-K 3 month · filed 2023-08-03 | 7.00K EUR 6-K · filed 2023-08-03 | 8.00K EUR derived: sum of 3 quarters · filed 2024-03-13 | -13.00K EUR derived: sum of 4 quarters · filed 2024-03-13 |
| 2022-03-31 | 5.00K EUR 6-K · filed 2023-05-16 | 6.00K EUR derived: sum of 2 quarters · filed 2024-03-13 | -15.00K EUR derived: sum of 3 quarters · filed 2024-03-13 | |
| 2021-12-31 | 1.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-03-13 | -20.00K EUR derived: sum of 2 quarters · filed 2024-03-13 | 31.00K EUR 20-F · filed 2024-03-13 | |
| 2021-09-30 | -21.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2022-11-09 | 30.00K EUR 6-K · filed 2022-11-09 | ||
| 2021-06-30 | 51.00K EUR 6-K · filed 2022-08-04 | |||
| 2020-12-31 | 38.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2023-03-29 | 77.00K EUR derived: sum of 2 quarters · filed 2023-03-29 | 145.00K EUR 20-F · filed 2023-03-29 | |
| 2020-09-30 | 39.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2021-11-04 | 107.00K EUR 6-K · filed 2021-11-04 | ||
| 2020-06-30 | 68.00K EUR 6-K · filed 2021-08-05 | |||
| 2019-12-31 | 155.00K EUR 20-F · filed 2022-04-29 |